Michael Byrnes E Ffector Therapeutics, Inc. (EFTR) insider trading activity

Michael Byrnes is Chief Financial Officer of eFFECTOR Therapeutics, Inc.. Currently has a direct ownership of 3,117 shares of EFTR, which is worth approximately $0. The most recent transaction as insider was on May 15, 2024, when has been sold 1,387 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $2,330. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.12K

0% 3M change

92.8% 12M change

Total Value Held $0

Michael Byrnes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	BUY Grant, award, or other acquisition	$2,330 $1.68 p/Share	1,387 Added 30.79%	3,117 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$2,262 $0.5 p/Share	4,524 Added 9.47%	43,271 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$2,236 $0.46 p/Share	4,863 Added 11.15%	38,747 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	$2,185 $0.47 p/Share	4,651 Added 12.07%	33,884 Common Stock
Jun 07 2022	BUY Open market or private purchase	$33,250 $1.33 p/Share	25,000 Added 46.1%	29,233 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$6,476 $1.53 p/Share	4,233 Added 50.0%	4,233 Common Stock

Also insider at

PBAXU

PHOENIX BIOTECH ACQUISITION CORP. Financial Services

Director

Michael Byrnes

Chief Financial Officer

Solana Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EFTR shares.

Notify only if

Value

Insider Trading

Get notified when an E Ffector Therapeutics, Inc. insider buys or sells EFTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to eFFECTOR Therapeutics, Inc.

Track Activities on EFTR

Account